You would be hard pressed finding another opportunity to buy a company with 3 core businesses , 2 of which are earning money & the 3rd being development of medical drugs for under $20 mill mc + cash to boast.
Future info:
Company revenues are expected to increase from $5+ million in 2017 to $15+ million by 2018.
THC also has an agreement to acquire Crystal Mountain and Dragon Vision (CMDV).
CMDV has traded for over five years with high profitability and will drive the majority of revenue and earnings for THC in 2017 and 2018.
The research and development business is anchored by the acquisition of Canndeo Limited, which provides THC with over 17 years of experience in the breeding, variety selection and growth management of cannabis.
The projected total economic impact of the U.S. cannabis industry is estimated to be between US$24.4 and US$44 billion for 2020, representing a 250% increase over 2016.
The medicinal cannabis market in Australia is estimated to be worth more than $100 million.
The cool-off you're probably thinking about where stocks are going back to $30 mill MC or there about's , IMO will not happen unless we have a black swan event as this trend looks solid on fundamental's.
personally think it's not mums & dads holding shares ( note i said holding & not trading ) on most of these listed & most of the calls on HC have been way wrong because of not seeing the bigger picture. a few have plenty of news to keep punters interested in the near term or till THC list next month. cheers
